Early life lipid profile and metabolic programming in very young children

K P J Wijnands1, S A Obermann-Borst1, R P M Steegers-Theunissen2

  • 1Department of Obstetrics and Gynecology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.

Insights

Childhood cholesterol levels are linked to epigenetic changes in tumor necrosis factor-alpha (TNFα) and leptin (LEP) genes, potentially influencing long-term cardiovascular disease risk.

Area of Science:

  • Epigenetics
  • Metabolic Programming
  • Cardiovascular Health

Background:

  • Early life lipid profiles may cause lasting epigenetic alterations.
  • Metabolic programming in infancy can impact future health.
  • Investigating early lipid-epigenetic links is crucial for developmental origins of health and disease (DOHaD).

Purpose of the Study:

  • To examine associations between serum lipids in young children and DNA methylation of TNFα and LEP.
  • To determine if maternal lipid profiles influence child DNA methylation.

Main Methods:

  • Analysis of serum lipid profiles and whole blood DNA methylation in 120 children at 17 months.
  • Utilized linear mixed models to assess exposure-specific differences.
  • Adjusted for covariates including gestational age, birth weight, sex, breastfeeding, and education.

Main Results:

  • Childhood total cholesterol correlated with reduced TNFα methylation.
  • HDL-cholesterol in children was associated with decreased methylation of both TNFα and LEP.
  • Maternal HDL-cholesterol showed an association with decreased child TNFα methylation.

Conclusions:

  • Childhood lipid levels are associated with epigenetic changes, supporting the DOHaD hypothesis.
  • These epigenetic modifications may influence future cardiovascular disease susceptibility.
  • Early life lipid-epigenetic interactions are key factors in metabolic programming.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
360
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
7.1K
Lipid Catabolism01:25

Lipid Catabolism

Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
1.4K
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
7.5K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
505
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.0K